Literature DB >> 8237233

Surgical management of primary retroperitoneal liposarcomas.

I Karanikas1, T Liakakos, S Koundourakis, A Papadopoulos, M Garsallah, S Dendrinos.   

Abstract

During a 21-year period (1970-1991), 7 patients with primary retroperitoneal liposarcomas were treated surgically in our department. All the tumours were excised completely, and in 2 patients an additional nephrectomy was performed. Postoperatively 4 patients had adjuvant radiotherapy. Two other patients received adjuvant chemotherapy. Both of them had to be reoperated, because of a local recurrence 12 and 9 months after their first operation. There was one death on the first postoperative day, and 4 patients died 1 1/2-2 years after the initial operation. Two patients are still alive 34 and 22 months after their first operation with recurrent disease. Adjuvant therapy proved to be ineffective on the survival of our patients. The prognosis of retroperitoneal liposarcomas continues to be poor and the primary treatment has to be aggressive with complete resection of the tumor.

Entities:  

Mesh:

Year:  1993        PMID: 8237233

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  3 in total

Review 1.  Primary retroperitoneal liposarcoma: a case report and review of the literature.

Authors:  E Ulusoy; S Beyribey; S Basşay; M Centinkaya
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  Computed tomographic distinction of perirenal liposarcoma from exophytic angiomyolipoma: a feature analysis study.

Authors:  James J Ellingson; Fergus V Coakley; Bonnie N Joe; Aliya Qayyum; Antonio C Westphalen; Benjamin M Yeh
Journal:  J Comput Assist Tomogr       Date:  2008 Jul-Aug       Impact factor: 1.826

3.  Multidetector Computed Tomography Features in Differentiating Exophytic Renal Angiomyolipoma from Retroperitoneal Liposarcoma: A Strobe-Compliant Observational Study.

Authors:  Qiushi Wang; Yu-Hsiang Juan; Yong Li; Jia-Jun Xie; Hui Liu; Hongfei Huang; Zaiyi Liu; Junhui Zheng; Ujwala S Saboo; Sachin S Saboo; Changhong Liang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.